Alisertib-impurities | Pharmaffiliates

Alisertib

Alisertib is an orally available Drug with potential antineoplastic activity. It is a selective inhibitor of aurora A kinase developed by Takeda. Reference standards of Alisertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Alisertib-API
    [catalogue_number] => PA 01 2730000
    [category_ids] => ,123,81,78,75,76,82,
    [chemical_name] => 
    [weight] => 518.93
    [form] => C27H20ClFN4O4
    [cas] => 1028486-01-2
    [pslug] => 1028486-01-2-alisertib-pa012730000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 01 2730000

Alisertib-API


  • Catalogue No.:PA 01 2730000

  • CAS :

    1028486-01-2

  • Molecular Formula : C27H20ClFN4O4

  • Molecular Weight : 518.93